Bioscience Animal Health PCL (BISm)

Currency in THB
2.54
-0.06(-2.31%)
Closed·

BISm Financial Summary

Key Ratios

P/E Ratio12.08
Price/Book1.03
Debt / Equity1.35%
Return on Equity9.48%
Dividend Yield5.51%
EBITDA107.79M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of THB (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.22%
Dividend Yield
5.51%
Industry Median 3.46%
Annualised payout
0.14
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
0.06 / --
Revenue / Forecast
573.78M / --
EPS Revisions
Last 90 days

FAQ

What were Bioscience Animal Health PCL's earnings for the latest quarter?

The Bioscience Animal Health PCL EPS (TTM) is 0.22. Bioscience Animal Health PCL reported sales of 573.78, net income of 18.61, and EPS of 0.06 for the latest quarter.

What was Bioscience Animal Health PCL's net income for the latest quarter?

Bioscience Animal Health PCL's net income for the latest quarter was 18.61.

How did Bioscience Animal Health PCL's performance compare year-over-year in the latest quarter?

The company's revenue moved from 663.26 in the previous quarter to 573.78 in the latest quarter, and net income moved from 18.28 to 18.61 compared to the previous quarter.

What is Bioscience Animal Health PCL's net profit margin on a TTM basis?

Bioscience Animal Health PCL's trailing twelve months (TTM) net profit margin is 2.74%.

How does Bioscience Animal Health PCL's debt to equity ratio compare to industry standards?

Bioscience Animal Health PCL's total debt-to-equity ratio is 1.35%.

What is Bioscience Animal Health PCL's return on investment on a TTM basis?

Bioscience Animal Health PCL's trailing twelve months (TTM) return on investment (ROI) is 9.48%.

Did Bioscience Animal Health PCL gain or lose cash last quarter?

In the latest quarter, Bioscience Animal Health PCL's net change in cash was -77.19 million.

What were Bioscience Animal Health PCL's total assets and liabilities in the latest quarter?

As of the latest quarter, Bioscience Animal Health PCL reported total assets of 1,235.41 million and total liabilities of 383.33 million.

How has Bioscience Animal Health PCL's total revenue grown this year?

Bioscience Animal Health PCL's total revenue was 663.26 in the previous quarter and 573.78 in the latest quarter.

What is Bioscience Animal Health PCL's gross margin on a TTM basis?

Bioscience Animal Health PCL's trailing twelve months (TTM) gross margin is 17.02%.

What was Bioscience Animal Health PCL's revenue per share for the latest quarter?

Bioscience Animal Health PCL's revenue per share for the latest quarter was 12.89.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.